EGFR and non-small cell lung carcinoma: It has recently been shown that inhibition of JAKs attenuates growth of small cell lung cancers in vitro and in vivo [58], and that activation of JAK signaling induces resistance to EGFR mutations in non-small cell lung cancers [59].